A Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG (Glycosaminoglycan) Levels in Aldurazyme® Treated Patients
This study has suspended participant recruitment.
(Study suspended due to low enrollment)
Sponsor:
Genzyme
Collaborator:
BioMarin/Genzyme LLC
Information provided by (Responsible Party):
Genzyme
ClinicalTrials.gov Identifier:
NCT00144768
First received: September 2, 2005
Last updated: April 8, 2013
Last verified: April 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has suspended participant recruitment. |
|---|---|
| Estimated Study Completion Date: | December 2013 |
| Primary Completion Date: | May 2007 (Final data collection date for primary outcome measure) |